Glimceed 2 VMF Tablet is a combination of Glimepiride (2 mg), Voglibose (0.2 mg), and Metformin Hydrochloride SR (500 mg), designed to provide effective control over blood sugar levels in Type 2 Diabetes Mellitus. This unique blend works by:
Glimepiride: Stimulating insulin secretion from the pancreas.
Voglibose: Slowing carbohydrate absorption in the intestines to control post-meal sugar spikes.
Metformin: Reducing liver glucose production and increasing muscle glucose uptake.
It is prescribed when diet, exercise, and single or dual-drug therapy are not enough to control blood sugar levels.
💊 Uses:
🌟 Benefits:
Triple mechanism for optimal glucose control
Reduces both fasting and post-meal glucose levels
Helps in long-term diabetes management
Single tablet convenience
⚠️ Side Effects:
Hypoglycemia (low blood sugar)
Gastrointestinal discomfort (bloating, diarrhea)
Flatulence
Rare: liver function abnormalities
📌 How to Use:
🛡️ Safety Advice:
Monitor blood sugar regularly
Avoid alcohol to reduce hypoglycemia risk
Not suitable for patients with severe kidney or liver disease
Use in pregnancy or breastfeeding only under medical advice
